Furthermore, a similar inflammatory response, characterized by increased levels of CXCL13, TNF, IFNγ, CXCL12, IL6, IL8, and IL10, has been detected in the cerebrospinal fluid of MS patients who exhibit high levels of gray matter damage at the time of diagnosis. The gene discussed is CXCL13; the disease is myeloid sarcoma.